GeneDx Holdings (WGS) stock

Genetic tests , market cap $1.9B

Exome and genome tests for rare diseases

Worth $1.9B

$54.83

-16.57%

As of Tuesday's close · Live for Pro members at the open

Why is WGS down?

Down 61% from its Nov 25, 2025 high.

It reported quarterly revenue of $123.1M on Nov 9; it fell 17% on Nov 10.

Sources: Price history, Nov 9, 2026; SEC filing, Nov 9, 2026

Tell me next time WGS moves

Free account, no card. An optional alert when WGS moves or its score changes.

Or see it live, free until Thursday morning. No account.

The other side, how the business stands, and the timeline, for Pro members.

Quality Score

-4

Poor

In its industry

#7of 7

Health Services

Checks firing

1of 14

Trending down

From 52-week high

-67.9%

under its best in a year

WGS's Quality Score fell 4 points on Tue, Nov 10, to -4.

See WGS's 14 chart checksSee it live, free until Thursday morning. No account. No card. Then keep going with a free account.

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

Key facts on WGS

Key facts on WGS
Holding it back	Moves 11.7% a day with no profit behind it
Latest filing	8-K, Nov 9 Reported its quarterly results

1 more reason behind WGS's -4, free with an account →6 more reasons behind WGS's -4, for Pro members.

WGS in the news

ReportLast night: sales of $123.1M; a loss of $0.41 a share. Lowered its outlook for the year. Past reports ›

In the newsGeneDx Research Demonstrates Medical Actionability of Exome and Genome Sequencing Results in Large Real-World Study of More Than 300,000 Patients Business Wire · 8:30 AM ET

WGS catalysts

Coming up

After its last 4 reports it closed -13.8% on average, higher 2 of 4 times.

17 past catalysts since 2021, with sizes and sources, for Pro members.

Why WGS scores -4

Poorfor quality, not price, 1 of 14 chart checks firingWhat the Quality Score means

−3Long-term trend below a falling 200-⁠day average, down over one year, down over two years
−2Volatility moves 11.7% a day on a $111M loss over four quarters, with no positive free cash flowA daily range of 5% or more with nothing behind it (no profit or cash flow, sales shrinking, or 10% more shares outstanding with no free cash flow): -1, or -2 from 8%.

Chart checks adds
Run-up adds
Profit subtractsRead on the last four quarters against the four before, or the last full year where no quarters are filed.
Growth addsSales and margins against a year earlier: up to +3 for fast growth and widening margins, down to -2 when both shrink.
Cash flow subtracts-1 when free cash flow over the last four quarters is negative.
News adds
Insider trades subtracts

No effect today: Size, Dilution, and Persistence.

What every line is worth, and the reason behind it, on WGS and every other stock.Get in free →

Price, score, chart checks, and the industry rank are from a snapshot taken at 11:29 PM ET, at least 15 minutes behind. How we rank stocks.

Tested. Our top-scored stocks returned 2.2x the average stock over the next month. Reconstructed after the fact; recorded live since Sep 9, 2026. How we tested it

How WGS ranks in Health Services

WGS is #7 of 7 by Quality Score.

How WGS ranks in Health Services
Rank	Stock	Checks	Quality Score
1	USPHUS Physical Therapy	6/14	14
2	LFSTLifeStance Health	4/14	12
3	PNTGThe Pennant	2/14	11
	INNVInnovAge		Open for its score
	PRVAPrivia Health		Open for its score
7	WGSGeneDx	1/14	-4

When does WGS report earnings, and what happens after?

Expected to report Mon Feb 22, after the close (in 104 days).

What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.

What WGS reported on Nov 9, 2026

The quarter

Sales of $123.1M, 5% more than a year ago; a loss of $0.41 a share, from $0.27.

The quarter that ended Sep 30, from the company's press release

The press release The filing on EDGAR

Where the sales came from

Where the quarter's sales came from
Line	Q3 2026	Q2 2026	Q3 2025
By product
Diagnostic Testup 5.8%	$120M97%	$112M98%	$114M97%

Each quarter's sales and their share of its total. Figures as filed (SEC filing, Nov 9)

4 more lines, for Pro members.

The outlook

The outlook the company gave, by period
Measure	Figure
Full year 2026
Exome and genome revenue growth	At least 17% growthcut

Figures as filed (SEC filing, Nov 9)

9 more outlook lines, for Pro members.

The numbers

Market value: $1.9B; today
Sales: $461M; up 14.6% on the year
Free cash flow: -$101M; last 12 months

Sales grew 19% a year over 5 years, fiscal 2020 to 2025.

4 more figures, for Pro members.

No analyst estimates on Breakaway: every figure here is filed.

The whole report on WGS: every line of its sales, every outlook beside the one it replaced, and the company's words, for Pro members.

Close after the report, last 3

-49.2%+4.5%-16.6%

May 4Aug 3Nov 9

Reported	When	Gap	Reaction	5 days
Nov 9, 2026After close	After close	-14.4%	-16.6%	not yet
Aug 3, 2026After close	After close	+12.0%	+4.5%	+14.8%
May 4, 2026After close	After close	-45.6%	-49.2%	-41.7%

WGS closed higher after 2 of its last 4 reports.

All 4 reports, and WGS's Quality Score going into each

WGS sales and profit by year

Sales and profit by year

Sales grew in four of the last six years, to $428M in 2025. It lost money in each of the seven years.

WGS has 1 of 14 chart checks firing

Trend1 of 5 shown

MA FAN 21 EMA W.EMA HH/HL 52W HI

Volume1 of 3 shown

VOL VDU U/D VOL

Tight range1 of 3 shown

ATR SQZ SQUEEZE NR7

Buying1 of 3 shown

OBV+CLOSE HI SPRING

The other 10 checks on WGS, and all 14 on every stock.Get in free →

WGS RSI today: 37.3, below its 50-day and 200-day averages

Not scored

RSI 37.3, MACD below signal, below both averages. Not scored.13 readings

The deep dive on WGS

What it does and how it makes money3 findingsAn operating loss of $13.1M in fiscal 2025, on $428M of sales.Annual report, filed Feb 23, 2026
Where it stands4 findingsFor Pro members4 findings on where WGS stands: its cash, debt, and share count, for Pro members
What changed in its filings2 findings"In particular, on September 7, 2022, a shareholder class action lawsuit was filed in the U.S. District Court for the District of Connecticut against the Company and certain of the Company’s current and former officers." (10-K for fiscal 2025)SEC filing · Feb 23, 2026Payor B made up 39% of its revenue in fiscal 2025, up from 32% in fiscal 2024.SEC filing · Feb 23, 2026
Who holds and trades it2 findingsFor Pro members2 findings on who holds and trades WGS, for Pro members

8 more findings on WGS, each with its source, for Pro members.

WGS insider trades

2 insiders bought $34.4M across 7 filings, and 2 insiders sold $3M across 22 filings, in the last 6 months. The newest:

SellKatherine Stueland$407KChief Executive Officerat $98.27 on Sep 16, filed Sep 18

SellKatherine StuelandChief Executive Officer$407Kat $98.27 on Sep 16, filed Sep 18

All 29 insider filings on WGS from the last six months, for Pro members.

All WGS insider trades

WGS's officers and directors

Officers and directors with a Form 4 in the last 12 months.

Katherine StuelandChief Executive Officer · 33 trades
Kevin FeeleyChief Financial Officer · 36 trades
Bryan DechairoChief Operating Officer · 5 trades
Joshua RuchDirector · 15 trades
Emily M. LeproustDirector · no trades on file
Jason RyanDirector · no trades on file
Richard C. Pfenniger Jr.Director · no trades on file
Thomas FuchsDirector · no trades on file

See insider trades by person

Which ETFs hold WGS?

In ETFs: WGS is under 0.1% of VTI, the most of the 24 funds Breakaway covers, by their holdings as filed for Jun 30, 2026.

About GeneDx Holdings

GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.

1,300 employeesStamford, CTgenedx.com

What GeneDx Holdings says it competes with

“Our competitors include companies that offer molecular genetic testing and consulting services, including specialty and reference laboratories that offer traditional single- and multi-gene tests.”

From its annual report, SEC filing · Feb 23, 2026

Here is what Pro members see.

The same page for Pro members, on Microsoft
Its Quality Score and rank, the line that drives it, and the live price.
The full chart
A year of candles to start, out to the whole history, with insider trades marked and the Quality Score under the price.
Every line of the score
Price action, the company, and signals, each with its points, on WGS and every other stock.
CEOs buying their own stock
Every CEO buy, biggest names first. Sort, filter, save the list, and set optional alerts.
Congress trades
A member's trades, newest first, each with its amount. Sort and filter the whole list.
14 chart checks, read for you
The ones firing on the stock, each in plain words, its rule a tap away.
Earnings, week by week
Who reports each day, and how each stock took its last four reports.
FDA dates, counted down
Each date in the company's words, its cash against the date, and an optional alert before it.
The market map
Every stock a box, colored by its Quality Score.
Themes, ranked live
Each theme's stocks ranked by Quality Score, live. Here, AI chips.
The top 10, every day
The ten highest Quality Scores at each close, kept day by day, week by week.
Optional alerts, your way
Pick a stock, a score, a price, a filing, or a whole scan. It tells you by push or email.
Your watchlist, scored
Your stocks by Quality Score, today's move, or name.
On your phone and your laptop
The same account and watchlist on both, each laid out for its screen.

Prices refresh every 2.5 seconds during market hours.
Optional alerts by push, email, or the bell.
Add it to your Home Screen and it opens like an app.

Pro members see every line of every stock's score.

What would turn WGS's score around: 8 things
2 more filings explained, a plain line each
Real-⁠time prices, no delay

BreakawaySep 18Katherine Stueland sold WGS$407K at $98.27, filed Sep 18

Alerts are optional.

See WGS's 14 chart checks

See it live, free until Thursday morning. No account. No card. Then keep going with a free account.

Straight AnswersStraight Answers

As of Nov 10, 2026: WGS's Quality Score is -4 (Poor), #7 of 7 in Health Services. Insiders bought $34.4M and sold $3M in the last 6 months (Form 4).

What does WGS's Quality Score say?

WGS scores -4 today, which Breakaway calls Poor. It is #7 of 7 in Services-⁠Health Services by Quality Score, with 1 of 14 chart checks firing. Down 61% from its Nov 25, 2025 high. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.

What is WGS's Quality Score?

WGS scores -4 today, which Breakaway calls Poor (below zero). That is #7 of 7 in Services-⁠Health Services by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind WGS's -4.

Are insiders buying WGS?

2 insiders bought $34.4M across 7 filings, and 2 insiders sold $3M across 22 filings, in the last 6 months. The newest is Katherine Stueland, Chief Executive Officer, who sold $407K on Sep 16. Every filing, with the scored weight, for Pro members.

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.